Heritage Glb (NASDAQ:HGBL) Stock, Quote.Headers.trade-ideas

Heritage Glb

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

News

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

HGBL

ISDR

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.

Insiders Buying Lee Enterprises And 2 Other Stocks

Long Ideas

BSPK

CPSH

RZLT

The Dow Jones index closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

$17M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

Social Media

General

AAPL

Many changes have been made to social media platform Twitter since Elon Musk acquired the company for $44 billion in 2022.

Twitter&#39;s Auction Encore: How To Bid On Apple Devices, Obama Art, And Classic Blue Birds Straight From HQ

Heritage Global Inc

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Uranium Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UEC#AMEX">UEC</a>) with a Buy and maintains $10.25 price target.

Price Target

Reiteration

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on Uranium Energy, Maintains $10.25 Price Target

Offerings

GFL Environmental Plans To Participate In Offering Of $210M Of Florida Development Finance Corporation Solid Waste Disposal Revenue Bonds

Tech YouTuber Marques Brownlee, popularly known as MKBHD, <a href="https://www.benzinga.com/news/24/09/40780100/apple-intelligence-ready-iphone-16-with-faster-processor-dedicated-camera-button-announced-check-pri">has reviewed the</a> iPhone 16 and iPhone 16 Pro models launched by Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) earlier this month. He also announced the launch of his new app, Panels.
What Happened: In a video posted on Tuesday, Brownlee shared his insights on the new iPhone models and introduced his new app, Panels.
Brownlee said that he has been testing the&nbsp;iPhone 16 and iPhone 16&nbsp;Pro for about two weeks and said, &#8220;This is the most unfinished I&#8217;ve ever seen a new iPhone launch.&#8221;
Here are the highlights from his review: 
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/09/40973399/apples-former-design-maestro-jony-ive-confirms-hes-joined-forces-with-openais-sam-altman-for-a-new-a?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple&#8217;s Former Design Maestro Jony Ive Confirms He&#8217;s Joined Forces With OpenAI&#8217;s Sam Altman For A New AI Hardware Project</a>
Design Changes: Aesthetically, the iPhone 16 introduces new colors and slightly larger camera protrusions. The overall shape remains familiar, but it includes new buttons: an&nbsp;Action Button&nbsp;and a&nbsp;Camera Control button.
Battery Capacity: While Apple claims improved battery life, actual measurements show only a slight increase in capacity (approximately 6% larger across the board). Brownlee reports that battery performance feels similar to last year, lasting a full day under heavy use.
Charging Speed: The new lineup supports up to&nbsp;45W wired charging&nbsp;and improved MagSafe wireless charging at&nbsp;25W, which Brownlee finds beneficial despite the lack of a fast charging brick included in the box.
Processor and RAM: The iPhone 16 models are equipped with A18 and A18 Pro chips, providing significant performance improvements for demanding tasks. Notably, both the Pro and non-Pro models now feature&nbsp;8GB of RAM, likely in preparation for future AI capabilities.
Camera Control Button: This new feature allows users more control over camera settings, such as exposure compensation and zoom. Brownlee highlighted that while the default photos may still carry an &#8220;iPhoney&#8221; look—overly brightened shadows—the new button gives users control over photography settings.
Regarding Apple Intelligence, Brownlee noted that Apple is introducing a suite of AI features branded as &#8220;Apple Intelligence&#8221; with the iPhone 16. 
However, he criticized the rollout, stating that much of the marketing focuses on these AI capabilities, which were not fully available at launch. He described the phone as feeling &#8220;unfinished&#8221; due to the absence of these promised features, despite Apple heavily promoting them during their launch events
The YouTuber also announced the launch of his new app, Panels, which is now live in the app store on iOS and Android. The app is a collection of wallpapers that have been featured in his videos over the years.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The iPhone 16&#8217;s launch has been met with mixed reactions. Despite&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40971882/as-apples-iphone-16-goes-on-sale-analyst-says-demand-off-to-strong-start-keeping-cu">analysts predicting strong demand</a> for the new model,&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40984092/apple-iphone-16-lead-time-falls-short-of-iphone-15-but-one-analyst-says-investors-s">lead times have been shorter</a>&nbsp;than the iPhone 15, raising concerns about weaker demand.
On the other hand, T-Mobile US Inc. CEO Mike Sievert has stated that the iPhone 16 is selling at a <a href="https://www.benzinga.com/markets/equities/24/09/40932937/apple-iphone-16-selling-at-a-greater-rate-than-last-year-says-t-mobile-ceo-amid-reports-of-lower">faster pace compared</a> to last year&#8217;s model.
Moreover, competition from Huawei&#8217;s new tri-fold phone&nbsp;could <a href="https://www.benzinga.com/news/24/09/40845772/huaweis-2-800-tri-fold-phone-has-the-potential-to-eat-apples-lunch-in-china-here-is-how-it-compares">pose a threat to Apple&#8217;s dominance</a> in the smartphone market.
Earlier it was reported that the iPhone 16 series&nbsp;<a href="https://www.benzinga.com/news/24/09/40785959/iphone-16-fails-to-sway-some-chinese-buyers-im-going-to-buy-huaweis-tri-fold-phone-missing-ai-featur" target="_blank" rel="noreferrer noopener">failed to impress some Chinese buyers</a>&nbsp;who cited the lack of AI features as the primary reason behind their discontent.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="iPhone 16/16 Pro Review: Times Have Changed!" width="500" height="281" src="https://www.youtube.com/embed/MRtg6A1f2Ko?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40968413/elon-musk-reacts-after-cathie-wood-labels-gavin-newsoms-threat-to-sue-tesla-ceo-over-memes-unconstit?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Reacts After Cathie Wood Labels Gavin Newsom&#8217;s Threat To Sue Tesla CEO Over Memes &#8216;Unconstitutional&#8217;: &#8216;…But That Didn&#8217;t Stop Them&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Apple

Tech

Marques Brownlee Reviews Apple's iPhone 16 And Launches New App: 'This Is The Most Unfinished I've Ever Seen A New iPhone Launch'

Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) reported quarterly earnings of $1.68 per share which beat the analyst consensus estimate of $1.43 by 17.48 percent. The company reported quarterly sales of $2.534 billion which beat the analyst consensus estimate of $2.471 billion by 2.56 percent. This is a 7.44 percent decrease over sales of $2.738 billion the same period last year.

Earnings

Earnings Beats

Thor Industries Q4 2024 GAAP EPS $1.68 Beats $1.43 Estimate, Sales $2.534B Beat $2.471B Estimate

MTAL

Metals Acquisition Plans To Seek Shareholder Approval To Change Company Name To 'MAC Copper Limited'

Needham analyst John Todaro maintains Hut 8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) with a Buy and raises the price target from $15 to $16.5.

Needham Maintains Buy on Hut 8, Raises Price Target to $16.5

Baird analyst Joe Vruwink initiates coverage on ResMed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) with a Outperform rating and announces Price Target of $280.

Initiation

Baird Initiates Coverage On ResMed with Outperform Rating, Announces Price Target of $280

HC Wainwright &amp; Co. analyst Scott Buck reiterates Mogo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOGO#NASDAQ">MOGO</a>) with a Buy and maintains $6 price target.

MOGO

HC Wainwright & Co. Reiterates Buy on Mogo, Maintains $6 Price Target

Baird analyst Joe Vruwink initiates coverage on TransMedics Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) with a Outperform rating and announces Price Target of $200.

TMDX

Baird Initiates Coverage On TransMedics Gr with Outperform Rating, Announces Price Target of $200

Baird analyst Joe Vruwink initiates coverage on Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Outperform rating and announces Price Target of $73.

PCOR

Baird Initiates Coverage On Procore Technologies with Outperform Rating, Announces Price Target of $73

Redburn Atlantic analyst Peter Low downgrades Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) from Buy to Neutral and raises the price target from $119 to $120.

Downgrades

Redburn Atlantic Downgrades Exxon Mobil to Neutral, Raises Price Target to $120

Redburn Atlantic analyst Peter Low downgrades BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) from Buy to Neutral.

Redburn Atlantic Downgrades BP to Neutral

RBC Capital analyst Nik Modi downgrades Kenvue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) from Outperform to Sector Perform and announces $24 price target.

KVUE

RBC Capital Downgrades Kenvue to Sector Perform, Announces $24 Price Target

Zuora customers can instantly activate its&nbsp;AI paywall&nbsp;in minutes for a deeper understanding of subscriber behavior to drive conversion and revenue growth.

Zuora Reveals New AI Enhancements At Subscribed Live London

Under the terms of the collaboration agreement, Generate will receive a total upfront payment of&nbsp;$65 million&nbsp;in cash from Novartis, which includes&nbsp;$15 million&nbsp;for the purchase of equity in Generate. Generate is also eligible to receive more than&nbsp;$1 billion&nbsp;in performance-based milestone payments, in addition to tiered royalties up to low double-digits. The number of targets and therapeutic areas are not being disclosed.

Contracts

Generate:Biomedicines Enters Multi-target Collaboration With Novartis To Discover, Develop Protein Therapeutics Across Multiple Disease Areas; Potential Total Transaction Valued At More Than $1B

IMMP

Immutep Received €2.19M R&D Tax Incentive Payment From French Government Under CIR Scheme

Macquarie analyst Ellie Jiang initiates coverage on DiDi Global (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DIDIY#OTC">DIDIY</a>) with a Outperform rating and announces Price Target of $5.5.

DIDI GLOBAL INC S/ADR by DiDi Global Inc.

DIDIY

Macquarie Initiates Coverage On DiDi Global with Outperform Rating, Announces Price Target of $5.5

BCLI

BrainStorm Cell Therapeutics Plans To Share Latest Update On NurOwn At This Year's NEALS Meeting

Catalyst Pharmaceuticals, Inc.&nbsp;("Catalyst" or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRX#NASDAQ">CPRX</a>), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that its sub-licensee in Japan, DyDo Pharma, Inc., ("DyDo") has reported that the Ministry of Health, Labor and Welfare of Japan has approved DyDo's New Drug Application ("NDA") to commercialize FIRDAPSE&#xAE; (amifampridine) Tablets 10 mg for treatment of patients with Lambert-Eaton Myasthenic Syndrome ("LEMS") in Japan. This approval marks a pivotal advancement in the treatment of LEMS, a rare autoimmune disorder that can severely impact quality of life and represents a significant step forward in addressing the unmet needs of patients affected by LEMS in Japan.
"We are pleased that our partner, DyDo, has secured regulatory approval for FIRDAPSE in Japan. This represents a meaningful milestone, bringing renewed hope to patients and further affirming FIRDAPSE's proven effectiveness in the treatment of LEMS," said Richard J. Daly, Catalyst's President and Chief Executive Officer. "This achievement underscores our unwavering commitment to advancing patient care. We appreciate the collaborative efforts of our partner in securing this approval, and we remain focused on expanding our innovative rare disease product portfolio beyond the U.S. to make a meaningful impact on patients' lives worldwide."
FIRDAPSE (amifampridine) is a leading therapy indicated in the United States for the treatment of LEMS in adults and pediatric patients six years of age and older. LEMS is a rare autoimmune disorder characterized by muscle weakness and fatigue. About 50% of people with LEMS have underlying cancer, as LEMS is observed in approximately 3% of small-cell lung cancer patients. FIRDAPSE is the only U.S. FDA-approved, evidence-based treatment for LEMS. As a cornerstone of Catalyst's commitment to serving those with rare diseases, FIRDAPSE is supported in the U.S. by a comprehensive patient support program to help ensure accessibility and assistance for eligible U.S. patients.

Government

Regulations

CPRX

Catalyst Pharma's FIRDAPSE Approved in Japan for Rare Autoimmune Disorder Lambert-Eaton Myasthenic Syndrome ("LEMS")

Buybacks

ARLO

Arlo Technologies Plans Repurchase Of Up To An Aggregate Of $50M Of Shares Of Its Common Stock

Warning: HGBL is at high risk of performing badly

There's a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Heritage Global (HGBL – Research Report) and Royal Ba...

Analysts Are Bullish on These Financial Stocks: Heritage Global (HGBL), Royal Bank Of Canada (RY)

In a report released today, George Sutton from Craig-Hallum reiterated a Buy rating on Heritage Global (HGBL – Research Report), with a price targe...

Craig-Hallum Reaffirms Their Buy Rating on Heritage Global (HGBL)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Heritage Glb (NASDAQ:<a href="https://investorplace.com/stock-quotes/hgbl-stock-quote/">HGBL</a>) just reported results for the second quarter of 2024.<ul><li>Heritage Glb reported earnings per share of 7 cents. This was below the analyst estimate for EPS of 9 cents.</li><li>The company reported revenue of $12.02 million.</li><li>This was 15.03% worse than the analyst estimate for revenue of $14.15 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/hgbl-stock-earnings-heritage-glb-for-q2-of-2024/">HGBL Stock Earnings: Heritage Glb Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

HGBL Stock Earnings: Heritage Glb Misses EPS, Misses Revenue for Q2 2024

Analysts have been eager to weigh in on the Financial sector with new ratings on Heritage Global (HGBL – Research Report), Optimumbank Holdings (OP...

Analysts Offer Insights on Financial Companies: Heritage Global (HGBL), Optimumbank Holdings (OPHC) and Walker & Dunlop (WD)

In a report released today, George Sutton from Craig-Hallum maintained a Buy rating on Heritage Global (HGBL – Research Report), with a price targe...

Craig-Hallum Remains a Buy on Heritage Global (HGBL)

Heritage Global Inc. (HGBL) Q2 2024 Earnings Call Transcript

Maxim Group analyst Michael Diana has maintained their bullish stance on HGBL stock, giving a Buy rating on August 9. Michael Diana's rating is bas...

Heritage Global: Resilient Growth and Undervaluation Signal a Strong Buy

Avoid Heritage Global As They Navigate A Loan Default

OPHC

Press Releases

Planet MicroCap Review Magazine for Winter/Spring 2024 Now Online

Heritage Global Inc. Reports Full Year 2023 Operating Income of $14.3 Million; Achieves $4.6 Million in Operating Income for Fourth Quarter 2023

Heritage Global to Announce First Quarter 2024 Results and Host Webcast on Thursday, May 9, 2024

Heritage Global Partners to Host Exclusive Online Auction of Solar Assets by Order of US Bankruptcy Court

Heritage Global Inc. Reports First Quarter 2024 Results

Heritage Global Partners and Integra Asset Solutions Host Exclusive Online Auction Featuring Furniture Manufacturing Equipment from Flexsteel Industries

Heritage Global to Announce Second Quarter 2024 Results and Host Webcast on Thursday, August 8, 2024

Heritage Global Partners to Host Exclusive Online Auction Featuring Premium Intellectual Property of Waitr Holdings Inc. – A Unique Opportunity for Innovators and Entrepreneurs

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Heritage Glb

Heritage Glb (HGBL) Forecast

Heritage Glb (NASDAQ:HGBL) Stock, Quote.Headers.trade-ideas